14th October 2015
The world's biodiversity is decreasing, human populations are continuously expanding and global climate change is impacting. It is likely that pandemics will also increase in volume and severity. Can science and technology protect our species survival? Do we need, or want, gene editing in the mix?
Alan Trounson, MSc, PhD, Dr, LLD, FRCOG, FANZCOG, FATSE
Emeritus Professor Monash University
Distinguished Scientist, Hudson Institute for Medical Research
Alan was President of Californian Institute for Regenerative Medicine (for 6.5 years; 2007-2014) the Californian state’s $3 billion stem cell agency driving research in stem cell biology and facilitating the translation of stem cell discoveries into clinical therapies.
He was a pioneer of human in vitro fertilisation (IVF), introducing fertility drugs for controlling ovulation, embryo freezing techniques, egg and embryo donation methods, early sperm microinjection methods, initiated embryo biopsy, developing in vitro oocyte maturation methods and the vitrification of eggs and embryos. He led the Australian team for the discovery of human embryonic stem cells in the late 1990’s.
He is now developing a new biotech start-up company in immune cell therapies for cancer and is a member of the Hudson Institute.
Venue: Collins Quarter
86 Collins Street, Melbourne
14th October 2015, 12:30pm - 2:00pm
Ticket Price includes GST
Bookings Close: 12th October 2015